HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Hydrochloric Acid → 2,2-Difluoro-6-[2-(3,4,5-trimethoxy-phenyl)-furo[3,2-b]pyridin-7-ylamino]-4H-benzo[1,4]oxazin-3-one

HRID 1470357
Print

Reaction equation

HRID 1470357 reaction equation
Cl[C:2]1[CH:7]=[CH:6][N:5]=[C:4]2[CH:8]=[C:9]([C:11]3[CH:16]=[C:15]([O:17][CH3:18])[C:14]([O:19][CH3:20])=[C:13]([O:21][CH3:22])[CH:12]=3)[O:10][C:3]=12.[NH2:23][C:24]1[CH:25]=[CH:26][C:27]2[O:32][C:31]([F:34])([F:33])[C:30](=[O:35])[NH:29][C:28]=2[CH:36]=1.Cl.O1CCOCC1>>[F:34][C:31]1([F:33])[C:30](=[O:35])[NH:29][C:28]2[CH:36]=[C:24]([NH:23][C:2]3[CH:7]=[CH:6][N:5]=[C:4]4[CH:8]=[C:9]([C:11]5[CH:16]=[C:15]([O:17][CH3:18])[C:14]([O:19][CH3:20])=[C:13]([O:21][CH3:22])[CH:12]=5)[O:10][C:3]=34)[CH:25]=[CH:26][C:27]=2[O:32]1
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

5

Reactant 4

HCID 313Hydrochloric AcidHCID 312751,4-DioxaneHCID 220611466-amino-2,2-difluoro-2H-benzo[b][1,4]oxazin-3(4H)-oneHCID 667789647-Chloro-2-(3,4,5-trimethoxyphenyl)furo[3,2-b]pyridine

Product 1

HCID 568488182,2-Difluoro-6-[2-(3,4,5-trimethoxy-phenyl)-furo[3,2-b]pyridin-7-ylamino]-4H-benzo[1,4]oxazin-3-oneYield 26%

Conditions

Temperature
150 °C

Procedure

To a 10 mL microwave vial with stirbar was added 7-chloro-2-(3,4,5-trimethoxyphenyl)furo[3,2-b]pyridine (25.00 mg; 0.08 mmol; 1.00 eq.) and 6-amino-2,2-difluoro-4H-benzo[1,4]oxazin-3-one (16.43 mg; 0.08 mmol; 1.05 eq.). The vial was sealed and flushed with N2 and the reagents were dissolved in NMP (1.00 ml). Hydrogen chloride in dioxane (0.02 ml; 4.00 M; 0.08 mmol; 1.05 eq.) was added and the reaction mixture was heated to 150° C. in a microwave reactor for 1 h. The reaction mixture was cooled to room temperature and quenched with NaOH(aq), extracted with EtOAc, dried (MgSO4) and concentrated on a rotary evaporator. The crude mixture was purified by Biotage chromatography (2-10% MeOH/CH2Cl2 15 column vol.; 10% MeOH/CH2Cl2 5 column vol.) to afford the title compound as a beige solid (10 mg, 26%). (HPLC (method F): 90%, RT: 4.69 min); 1H NMR (400 MHz, DMSO-d6) δ [ppm] 11.99 (s, 1H), 9.14 (s, 1H), 8.17 (d, J=5.5, 1H), 7.57 (s, 1H), 7.35 (d, J=8.8, 1H), 7.22 (s, 2H), 7.08-7.00 (m, 2H), 6.88 (d, J=5.5, 1H), 3.85 (s, 6H), 3.72 (s, 3H); MS (m/z) 484 [M+H]+, RT: 2.9 min.

Workup

  1. customThe vial was sealed
  2. customflushed with N2
  3. dissolutionthe reagents were dissolved in NMP (1.00 ml)
  4. temperatureThe reaction mixture was cooled to room temperature
  5. customquenched with NaOH(aq)
  6. extractionextracted with EtOAc
  7. dry with materialdried (MgSO4)
  8. concentrationconcentrated on a rotary evaporator
  9. customThe crude mixture was purified by Biotage chromatography (2-10% MeOH/CH2Cl2 15 column vol.; 10% MeOH/CH2Cl2 5 column vol.)

Sources & evidence

ORD record
ord-351b44eb0ad54b1aad26d3d4cf7209ee
Source dataset
uspto-grants-2015_04
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US09006440B2

Reaction notes

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes